Marquette Asset Management’s Insmed INSM Stock Holding History

Marquette Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-28	Closed	-$4.87K	–	855
2025 Q4	$4.87K	Hold	28	–	–	﹤0.01%	326
2025 Q3	$4.03K	Buy	+28	New	+$3.43K	﹤0.01%	377

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Marquette Asset Management's INSM Position: Q1 2026 in Review

Marquette Asset Management sold out of Insmed (INSM) in Q1 2026, closing a stake of 28 shares — an estimated $4.87K sold.

Marquette Asset Management first reported a position in INSM in Q3 2025 and held it in 2 quarters. The position peaked at $4.87K in Q4 2025. 672 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Marquette Asset Management reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
Marquette Asset Management sold 28 Insmed shares in Q1 2026, an estimated $4.87K.
Marquette Asset Management first reported a position in Insmed in Q3 2025 and held it in 2 quarters.
Marquette Asset Management's Insmed position peaked at $4.87K in Q4 2025.
672 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Marquette Asset Management's 13F filing for Q1 2026, filed 24 Apr 2026.